Erratum: Global health 2035: a world converging within a generation (The Lancet (2013) 382(9908) (1898–1955) (S0140673613621054) (10.1016/S0140-6736(13)62105-4));Global health 2035: A world converging within a generation

The Lancet

Volumn 382, Issue 9908, 2013, Pages 1898-1955

  Jamison, Dean T ^a   Summers, Lawrence H ^b   Alleyne, George ^d   Arrow, Kenneth J ^e   Berkley, Seth ^f   Binagwaho, Agnes ^g   Bustreo, Flavia ^h   Evans, David ⁱ   Feachem, Richard G A ^j   Frenk, Julio ^c   Ghosh, Gargee ^k   Goldie, Sue J ^c   Guo, Yan ^l   Gupta, Sanjeev ^m   Horton, Richard ⁿ   Kruk, Margaret E ^o   Mahmoud, Adel ^p   Mohohlo, Linah K ^q   Ncube, Mthuli ^r   Pablos Mendez, Ariel ^t   Reddy, K Srinath ^u   Saxenian, Helen ^v   Soucat, Agnes ^s   Ulltveit Moe, Karene H ^w   Yamey, Gavin ^a   more..

^a UNIVERSITY OF WASHINGTON   (United States)

^b HARVARD UNIVERSITY   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF THE WEST INDIES   (Jamaica)

^e STANFORD UNIVERSITY   (United States)

^f GAVI Alliance   (Switzerland)

^g Ministry of Health   (Rwanda)

^h Family Youth and Children's Law Services   (Australia)

ⁱ WORLD HEALTH ORGANIZATION   (Switzerland)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k BILL AND MELINDA GATES FOUNDATION   (United States)

^l PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^m INTERNATIONAL MONETARY FUND   (United States)

ⁿ THE LANCET   (United Kingdom)

^o Columbia University ^*  (United States)

^p PRINCETON UNIVERSITY   (United States)

^q Bank of Botswana   (Botswana)

^r Economist's Offi Ce   (United Kingdom)

^s AFRICAN DEVELOPMENT BANK   (Tunisia)

^t UNITED STATES AGENCY FOR INTERNATIONAL DEVELOPMENT   (United States)

^u PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^v RESULTS FOR DEVELOPMENT INSTITUTE   (United States)

^w UNIVERSITY OF OSLO   (Norway)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CARDIOVASCULAR DISEASE; COST EFFECTIVENESS ANALYSIS; DISABILITY; ECONOMIC DEVELOPMENT; GOVERNMENT; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH INSURANCE; HEALTH SERVICE; HUMAN; INCOME; INJURY; INVESTMENT; LIFE EXPECTANCY; LOWEST INCOME GROUP; MATERNAL MORTALITY; MENTAL DISEASE; NEUROLOGIC DISEASE; NON COMMUNICABLE DISEASE; PREMATURE MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR; SCALE UP; SUSTAINABLE DEVELOPMENT; TUBERCULOSIS;

EID: 84889255185     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)60073-8     Document Type: Erratum

References (268)

1. World Bank. World Development Report. 1993. http://fi les.dcp2. org/pdf/WorldDevelopmentReport1993.pdf (accessed Feb 4, 2013).
2. Deaton A. The World Development Report at 30: a birthday tribute or a funeral elegy? In: Yusuf S, ed. Development economics through the decades: a critical look at thirty years of the World Development Report. Washington, DC: World Bank, 2008: 105-114.
3. Institute for Health Metrics and Evaluation. Financing global health 2012: the end of the golden age? http://www.healthmetricsandevalu ation.org/ publications/policy-report/fi nancing-global-health-2012-end-golden-age (accessed Feb 12, 2013)
4. WHO. Global status report on road safety 2013: supporting a decade of action. Geneva: World Health Organization, 2013.
5. Cropper M, Hammitt JK, Robinson LA. Valuing mortality risk reductions: progress and challenges. Resources for the Future Discussion Paper no. 11-10. http://papers.ssrn.com/sol3/papers. cfm?abstract-id=1788975 (accessed Oct 17, 2013).
6. Mahbubani K. The great convergence. Asia, the West, and the logic of one world. New York: Public Aff airs, 2013.
7. WHO. World Health Report 1999: making a diff erence. Geneva: World Health Organization, 1999.
8. WHO. Macroeconomics and health: investing in health for economic development. Geneva: World Health Organization, 2001.
9. WHO. Closing the gap in a generation: health equity through action on the social determinants of health. Final report of the Commission on Social Determinants of Health. Geneva: World Health Organization, 2008.
10. Collier P. The bottom billion: why the poorest countries are failing and what can be done about it. New York: Oxford University Press, 2007.
11. The Lancet. World Bank's cure for donor fatigue. Lancet 1993; 342: 63-64.
12. United Nations. United Nations Special Session on Children. Guest speeches: Bill Gates, Jr, Co-founder of the Bill & Melinda Gates Foundation. 2002. http://www.unicef.org/specialsession/ press/02espbillgates.htm (accessed Oct 3, 2013).
13. Specter M. What money can buy. New Yorker (New York), Oct 24, 2005. http://www.michaelspecter.com/2005/10/what-money-canbuy (accessed Feb 21, 2013).
14. Lopez AD. Causes of death: an assessment of global patterns of mortality around 1985. World Health Stat Q 1990; 43: 91-104.
15. Lopez AD. Causes of death in industrial and developing countries: estimates for 1985-90. In: Jamison DT, Mosley WH, Measham AR, Bobadilla JL, eds. Disease control priorities in developing countries. New York: Oxford University Press, 1993: 35-50.
16. Zeckhauser R, Shepard DS. Where now for saving lives? Law Contemp Probl 1976; 40: 5-45.
17. Barnum H. Evaluating healthy days of life gained from health projects. Soc Sci Med 1987; 24: 833-41.
18. Ghana Health Assessment Project Team. A quantitative method of assessing the health impact of diff erent diseases in less developed countries. Int J Epidemiol 1981; 10: 73-80.
19. Murray CJ, Lopez AD, Jamison DT. The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bull World Health Organ 1994; 72: 495-509.
20. Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2197-223.
21. WHO. Global health estimates summary tables: deaths by cause, age and sex by various regional grouping. Geneva: World Health Organization, 2013. http://www.who.int/healthinfo/global- burden-disease/en/ (accessed Oct 17, 2013).
22. Hill K, Zimmerman L. Adolescent mortality in low-and middleincome countries. Commission on Investing in Health Working Paper, 2013. http://globalhealth2035.org (accessed Nov 8, 2013).
23. Jamison DT, Breman JG, Measham AR, et al, eds. Disease control priorities in developing countries, 2nd edn. Washington, DC and New York: The World Bank and Oxford University Press, 2006.
24. Jamison DT, Mosley WH, Meashem AR, Bobadilla JL, eds. Disease control priorities in developing countries,1st edn. New York: Oxford University Press, 1993.
25. Misra R. Disease control priorities in developing countries, second edition: perspective of a policymaker. 2006. http://www.dcp2.org/ main/ExpertEssays.html (accessed Oct 17, 2013).
26. Abbasi K. The World Bank on world health: under fi re. BMJ 1999; 318: 1003-06.
27. Costello A, Woodward D. World Bank's world development report. Lancet 1993; 342: 440-41.
28. Kuhn L, Zwarenstein MF, Thomas GC, et al. Village health-workers and GOBI-FFF. An evaluation of a rural programme. S Afr Med J 1990; 77: 471-75.
29. Walsh JA, Warren KS. Selective primary health care: an interim strategy for disease control in developing countries. N Engl J Med 1979; 301: 967-74.
30. Jayasinghe KS, De Silva D, Mendis N, Lie RK. Ethics of resource allocation in developing countries: the case of Sri Lanka. Soc Sci Med 1998; 47: 1619-25.
31. Berman PA, Bossert TJ. A decade of health sector reform in developing countries: what have we learned? 2000. http://www. hsph.harvard.edu/ihsg/ publications/pdf/closeout.PDF (accessed Oct 17, 2013).
32. Rowden R. The ghosts of user fees past: exploring accountability for victims of a 30-year economic policy mistake. Health Hum Rights J 2013; 15: 175-85.
33. The Lancet. The struggle for universal health coverage. Lancet 2012; 380: 859.
34. UN Inter-agency Group for Child Mortality Estimation. Levels and trends in child mortality report 2012. New York: United Nations Children's Fund, 2012.
35. UN Inter-agency Group for Maternal Mortality Estimation. Trends in maternal mortality 1990 to 2010: WHO, UNICEF, UNFPA, and the World Bank Estimates. Geneva: World Health Organization, 2012.
36. Vallin J, Meslé F. The segmented trend line of highest life expectancies. Popul Dev Rev 2009; 35: 159-87.
37. United Nations Development Programme. Human Development Report 2013. The rise of the south: human progress in a diverse world. New York: United Nations Development Programme, 2013.
38. World Bank. Financing health care: issues and options for China. Washington, DC: World Bank, 1997.
39. United Nations, Department of Economic and Social Aff airs, Population Division. Sex diff erentials in childhood mortality. New York: United Nations, 2011.
40. Victora CG, Barros AJD, França G, Restrepo MC. Selected analyses on inequalities in under-5 mortality rates and related indicators in low and middle-income countries, 2000-2010. Commission on Investing in Health Working Paper, 2013. http://globalhealth2035. org (accessed Oct 22, 2013).
41. Guilmoto CZ. Skewed sex ratios at birth and future marriage squeeze in China and India, 2005-2100. Demography 2012; 49: 77-100.
42. Howitt P, Darzi A, Yang G-Z, et al. Technologies for global health. Lancet 2012; 380: 507-35.
43. Guillet P, Alnwick D, Cham MK, et al. Long-lasting treated mosquito nets: a breakthrough in malaria prevention. Bull World Health Organ 2001; 79: 998.
44. Sinclair D, Zani B, Donegan S, Olliaro P, Garner P. Artemisinin-based combination therapy for treating uncomplicated malaria. Cochrane Database Syst Rev 2009; 3: CD007483.
45. Wang JQ, Liu M, Liu A, Li H. Global health governance in china: the case of China's health aid to foreign countries. In: Lee K, Pang T, Tan Y, eds. Asia's role in governing global health. New York: Routledge, 2013: 39-65.
46. Jamison DT, Sandbu M, Wang J. Why has infant mortality decreased at such diff erent rates in diff erent countries? Working paper no. 21. Bethesda: Disease Control Priorities Project, 2004.
47. Commission on Health Research for Development. Health research: essential link to equity in development. Report of the Commission on Health Research for Development. New York, NY: Oxford University Press, 1990.
48. Røttingen J-E, Regmi S, Eide M, et al. Mapping of available health research and development data: what's there, what's missing and what role is there for a global observatory. Lancet 2013; 383: 1286-307.
49. Moran M, Guzman J, Henderson K, et al. G-FINDER, 2012: neglected disease research and development: a fi ve year review. Sydney: Policy Cures, 2012.
50. Mahoney RT. Product development partnerships: case studies of a new mechanism for health technology innovation. Health Res Policy Syst 2011; 9: 33.
51. Moran M. A breakthrough in R&D for neglected diseases: new ways to get the drugs we need. PLoS Med 2005; 2: e302.
52. IFPMA (International Federation of Pharmaceutical Manufacturers and Associations). Pharmaceutical R&D projects to discover cures for patients with neglected conditions. 2012. http://www.ifpma.org/ fi leadmin/content/ Publication/2013/IFPMA-R-D-Status-Report- Neglected-Conditions.pdf (accessed Feb 14, 2013).
53. Gutteridge WE. TDR collaboration with the pharmaceutical industry. Trans R Soc Trop Med Hyg 2006; 100 (suppl 1): S21-25.
54. Moran M. Global health policy responses to the world's neglected diseases. In: Brown GW, Yamey G, Wamala S, eds. The handbook of global health policy. Oxford: Wiley Blackwell, 2013 (in press).
55. Morel CM, Acharya T, Broun D, et al. Health innovation networks to help developing countries address neglected diseases. Science 2005; 309: 401-04.
56. GAVI. 2013. http://www.gavialliance.org/about/partners/ developing-country-vaccine-industry/ (accessed Oct 17, 2013).
57. Waning B, Diedrichsen E, Moon S. A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries. J Int AIDS Soc 2010; 13: 35.
58. DSW, Policy Cures. Saving lives and creating impact: EU investment in poverty-related neglected diseases. 2012. http:// policycures.org/downloads/ DSWreport.pdf (accessed May 8, 2013)
59. Pedrique B, Some C, Ford N, Olliaro P, Strub-Wourgaft N, Bradol J-H. The drug and vaccine pipeline for neglected diseases, 2000-2011: a systematic assessment. 2012. http://www. doctorswithoutborders.org/events/symposiums/2012- lives-in-thebalance/ assets/fi les/JH-Bradol-The-Drug-and-Vaccine-Pipeline-for- Neglected-Diseases.pdf (accessed Feb 14, 2013)
60. del Rio C, Sepúlveda J. AIDS in Mexico: lessons learned and implications for developing countries. AIDS 2002; 16: 1445-57.
61. Clift C. Identifying sustainable methods for improving global health security and access to health care. Chatham House Working Paper, April 2013. http://www.chathamhouse.org/publications/papers/ view/192809 (accessed Oct 17, 2013).
62. Elovainio R, Evans DB. Raising and spending domestic money for health. Chatham House Working Paper, May 2013. http://www. chathamhouse.org/ publications/papers/view/191335 (accessed Oct 17, 2013).
63. Easterlin R. How benefi cent is the market? A look at the modern history of morality. Res Econ Hist 1999; 3: 257-94.
64. Pritchett L, Summers LH. Wealthier is healthier. J Hum Resour 1996; 31: 841-68.
65. Davis K. The amazing decline of mortality in underdeveloped areas. Am Econ Rev 1956; 46: 305-18.
66. Pison G, Trape JF, Lefebvre M, Enel C. Rapid decline in child mortality in a rural area of Senegal. Int J Epidemiol 1993; 22: 72-80.
67. WHO. The Abuja declaration ten years on. 2011. http://www.who. int/healthsystems/publications/Abuja10.pdf (accessed Oct 17, 2013).
68. World Bank. World Development Indicators, 2013. Washington, DC: World Bank, 2013.
69. Foreign policy and fund for peace. http://www.foreignpolicy.com/ failed-states-index-2012-interactive (accessed Oct 17, 2013).
70. Blanchet N, Thomas M, Atun R, Knaul F, Jamison D, Hecht R. Global collective action in health: The WDR+20 landscape of core and supportive functions. Commission on Investing in Health Working Paper, 2013. http://globalhealth2035.org (accessed Oct 22, 2013).
71. Akachi Y, Atun R. Eff ect of investment in malaria control on child mortality in sub-Saharan Africa in 2002-2008. PLoS One 2011; 6: e21309.
72. Walz J, Ramachandran V. Brave new world: a literature review of emerging donors and the changing nature of foreign assistance. Center for Global Development (CGD) Working Paper 273. 2011. http://www.cgdev.org/content/ publications/detail/1425691 (accessed Oct 17, 2013).
73. Center for Global Development. Value for money: an agenda for global health funding agencies. 2012. http://www.cgdev.org/section/ topics/global-health/working-groups/value-for-money (accessed Oct 17, 2013).
74. Moon S, Omole O. Draft Chatham House background paper: development assistance for health: critiques and proposals for change. http://www. chathamhouse.org/publications/papers/ view/190951 (accessed Oct 17, 2013).
75. Biesma R, Brugha R, Harmer A, Walsh A, Spicer N, Walt G. The eff ects of global health initiatives on country health systems: a review of the evidence from HIV/AIDS control. Health Policy Plan 2009; 24: 239-52.
76. Dybul M, Piot P, Frenk J. Reshaping global health. Hoover Institution Policy Review, no. 173, June 1, 2012. http://www. hoover.org/publications/ policy-review/article/118116 (accessed May 7, 2013).
77. Legge D. Future of WHO hangs in the balance. BMJ 2012; 345: e6877.
78. The Economist. Pre-empting pandemics: an ounce of prevention. April 20, 2013. http://www.economist.com/news/science-andtechnology/ 21576375-new-viruses- emerge-china-and-middle-eastworld-poorly-prepared (accessed May 7, 2013).
79. Fink G, Hill K. Urbanization and child mortality-evidence from the Demographic and Health Surveys. Commission on Investing in Health Working Paper, 2013. http://globalhealth2035.org (accessed Oct 22, 2013).
80. United Nations, Department of Economic and Social Aff airs, Population Division. World urbanization prospects, the 2011 revision. http://esa.un.org/ wpp/ppt/CSIS/WUP-2011-CSIS-4.pdf (accessed Oct 17, 2013).
81. Glassman A, Duran D, Sumner A. Global health and the new bottom billion: how funders should respond to shifts in global poverty and disease burden. Washington, DC: Center for Global Development, January 2011. http://www.cgdev.org/doc/full-text/BottomBillion/ Glassman-Bottom-Billion.html#- ftn2 (accessed May 8, 2013).
82. Feachem RGA, Kjellstrom T, Murray CJL, Over M, Phillips MA, eds. The health of adults in the developing world. New York: Oxford University Press, 1992.
83. Bobadilla JL, Frenk J, Lozano R, Frejka T, Stern C. The epidemiological transition and health priorities. In: Jamison DT, Mosley WH, Meashem AR, Bobadilla JL, eds. Disease control priorities in developing countries, 1st edn. New York: Oxford University Press, 1993: 51-63.
84. Sawyer SM, Afi fi RA, Bearinger LH, et al. Adolescence: a foundation for future health. Lancet 2012; 379: 1630-40.
85. WHO. Every woman, every child: strengthening equity and dignity through health. The second report of the independent Expert Review Group (iERG) on Information and Accountability for Women's and Children's Health. Geneva: World Health Organization, 2013.
86. Marquez PV, Farrington JL. The challenge of non-communicable diseases and road traffi c injuries in sub-Saharan Africa. An overview. Washington, DC: The World Bank, 2013.
87. Mackey TK, Liang BA. Rebalancing brain drain: exploring resource reallocation to address health worker migration and promote global health. Health Policy 2012; 107: 66-73.
88. Joint Learning Initiative. Human resources for health. Overcoming the crisis. 2004. http://www.who.int/hrh/documents/JLi-hrh- report.pdf (accessed Oct 17, 2013).
89. Frenk J, Chen L, Bhutta ZA, et al. Health professionals for a new century: transforming education to strengthen health systems in an interdependent world. Lancet 2010; 376: 1923-58.
90. Fidler DP, Drager N, Lee K. Managing the pursuit of health and wealth: the key challenges. Lancet 2009; 373: 325-31.
91. Stuckler D, Nestle M. Big food, food systems, and global health. PLoS Med 2012; 9: e1001242.
92. Di Cesare M, Khang Y-H, Asaria P, et al, and the Lancet NCD Action Group. Inequalities in non-communicable diseases and eff ective responses. Lancet 2013; 381: 585-97.
93. Costello A, Abbas M, Allen A, et al. Managing the health eff ects of climate change: Lancet and University College London Institute for Global Health Commission. Lancet 2009; 373: 1693-733.
94. Xu K, Evans DB, Carrin G, Aguilar-Rivera AM, Musgrove P, Evans T. Protecting households from catastrophic health spending. Health Aff 2007; 26: 972-83.
95. Kruk ME, Goldmann E, Galea S. Borrowing and selling to pay for health care in low-and middle-income countries. Health Aff 2009; 28: 1056-66.
96. van der Gaag J, Śtimac V. Towards a new paradigm for health sector development. Amsterdam Institute for International Development, 2008. http://www.resultsfordevelopment.org/sites/ resultsfordevelopment.org/fi les/resources/Toward a New Paradigm for Health Sector Development.pdf (accessed Oct 17, 2013).
97. Clements B, Coady D, Gupta S, eds. The economics of public healthcare reform in advanced and emerging economies. Washington, DC: International Monetary Fund, 2012. http://www. imf.org/external/pubs/ft/books/2012/health/ healthcare.pdf (accessed April 26, 2013).
98. Bloom DE, Canning D. Policy forum: public health. The health and wealth of nations. Science 2000; 287: 1207-09.
99. Bloom DE, Canning D, Jamison DT. Health, wealth, and welfare. Finance Dev 2004; 41: 10-115.
100. Bloom DE, Fink G. The economic case for devoting public resources to health. In: Farrar J, Hotez PJ, Junghanss T, Kang G, Lalloo D, White NJ, eds. Manson's Tropical Diseases, 23rd edn. Philadelphia, PA: Saunders (in press).
101. Ruger JP, Jamison DT, Bloom E. Health and the economy. In: Merson MH, Black RE, Mills AJ, eds. International public health, 2nd edn. Sudbury: Jones and Barlett, 2006: 601-47.
102. Alleyne GA, Cohen D. Health, economic growth, and poverty reduction. The report of working group 1 of the Commission on Macroeconomics and Health. Geneva: World Health Organization, 2002. http://whqlibdoc.who.int/publications/ 9241590092.pdf (accessed April 26, 2013).
103. Fogel RW. New fi ndings on secular trends in nutrition and mortality: some implications for population theory. In: Rosenzweig M, Stark O, eds. Handbook of population and family economics, vol 1A. Amsterdam: Elsevier, 1997: 483-81.
104. Thomas D, Frankenberg E. Health, nutrition and prosperity: a microeconomic perspective. Bull World Health Organ 2002; 80: 106-13.
105. Strauss J, Thomas D. Health, nutrition, and economic development. J Econ Lit 1998; 36: 766-817.
106. Bloom DE, Sachs JD. Geography, demography, and economic growth in Africa. Brookings Pap Econ Act 1998; 2: 207-95.
107. Gallup JL, Sachs JD. The economic burden of malaria. Am J Trop Med Hyg 2001; 64 (suppl): 85-96.
108. Acemoglu D, Johnson S. Disease and development: the eff ect of life expectancy on economic growth. J Polit Econ 2007; 115: 925-84.
109. Bloom D, Canning D, Fink G. Disease and development revisited. National Bureau of Economic Research Working Paper 15137. 2009. http://www.nber.org/ papers/w15137 (accessed March 13, 2013).
110. Jamison DT, Lau LJ, Wang J. Health's contribution to economic growth in an environment of partially endogenous technical progress. In: Lopez-Casasnovas G, Rivera B, Currais L, eds. Health and economic growth: fi ndings and policy implications. Cambridge, MA: The MIT Press, 2005: 67-91.
111. Cameron TA. Euthanizing the value of a statistical life. Rev Environ Econ Policy 2010; 4: 161-78.
112. Usher D. An imputation to the measure of economic growth for changes in life expectancy. In: Moss M, ed. The measurement of economic and social performance. New York: Columbia University Press for National Bureau of Economic Research, 1973.
113. Williamson JG. British mortality and the value of life, 1781-1931. Popul Stud 1984; 38: 157-72.
114. Nordhaus W. The health of nations: the contribution of improved health to living standards. In: Murphy K, Topel R, eds. Measuring the gains from medical research: an economic approach. Chicago: University of Chicago Press, 2003: 9-40.
115. Suhrcke M, Arce RS, McKee M, Rocco L. Economic costs of ill health in the European Region. In: Figueras J, McKee M, eds. Health systems, health, wealth and societal well-being. Maidenhead: Open University Press, 2012.
116. Bourguignon F, Morrisson C. Inequality among world citizens: 1820-1992. Am Econ Rev 2002; 92: 727-44.
117. Becker GS, Philipson TJ, Soares RR. The quantity and quality of life and the evolution of world inequality. Am Econ Rev 2005; 95: 277-91.
118. Bloom DE, Mahal AJ. Does the AIDS epidemic threaten economic growth? J Econom 1997; 77: 105-24.
119. Crafts N, Haacker M. Welfare implications of HIV/AIDS. In: Haacker M, ed. The macroeconomics of HIV/AIDS. Washington, DC: International Monetary Fund, 2004: 182-97.
120. Philipson TJ, Soares RR. The economic cost of AIDS in Sub-Saharan Africa: a reassessment. In: Lopez-Casanovas G, Rivera B, Currais L, eds. Health and economic growth: fi ndings and policy implications. Cambridge, MA: The MIT Press, 2005: 315-38.
121. Institute of Medicine Committee on Issues and Priorities for New Vaccine Development, Division of Health Promotion and Disease Prevention. New vaccine development: establishing priorities: volume 1, diseases of importance in the United States. Washington, DC: National Academics Press, 1985.
122. Eggleston K, Fuchs V. The new demographic transition: most gains in life expectancy now realized late in life. J Econ Perspect 2012; 26: 137-56.
123. Kydland FE, Mundell R, Schelling T, Smith V, Stokey N. Expert panel ranking. In: Lomberg B, ed. Global problems, smart solutions: costs and benefi ts. Cambridge: Cambridge University Press, 2013: 701-16.
124. Alkire BC, Vincent JR, Burns CT, Metzler IS, Farmer PE, Meara JG. Obstructed labor and caesarean delivery: the cost and benefi t of surgical intervention. PLoS One 2012; 7: e34595.
125. Arrow K, Dasgupta P, Goulder LH, Mumford KJ, Oleson K. Sustainability and the measurement of wealth. Environ Dev Econ 2012; 17: 317-53.
126. United Nations University-International Human Dimensions Programme on Global Environmental Change, United Nations Environment Programme. Inclusive wealth report 2012, measuring progress towards sustainability. Cambridge: Cambridge University Press, 2012. http://www.unep.org/pdf/IWR-2012.pdf (accessed April 28, 2013).
127. Sepúlveda J, Bustreo F, Tapia R, et al. Improvement of child survival in Mexico: the diagonal approach. Lancet 2006; 368: 2017-27.
128. WHO. Everybody's business: strengthening health systems to improve health outcomes: WHO's framework for action. Geneva: World Health Organization, 2007.
129. Chen L, Evans T, Anand S, et al. Human resources for health: overcoming the crisis. Lancet 2004; 364: 1984-90.
130. Hsia RY, Mbembati NA, Macfarlane S, Kruk ME. Access to emergency and surgical care in sub-Saharan Africa: the infrastructure gap. Health Policy Plan 2012; 27: 234-44.
131. Kruk ME, Porignon D, Rockers PC, Van Lerberghe W. The contribution of primary care to health and health systems in low-and middle-income countries: a critical review of major primary care initiatives. Soc Sci Med 2010; 70: 904-11.
132. Rabkin M, Kruk ME, El-Sadr WM. HIV, aging and continuity care: strengthening health systems to support services for noncommunicable diseases in low-income countries. AIDS 2012 26 (suppl 1): S77-83.
133. Croghan TW, Beatty A, Ron A. Routes to better health for children in four developing countries. Milbank Q 2006; 84: 333-58.
134. Farmer PE, Nutt CT, Wagner CM, et al. Reduced premature mortality in Rwanda: lessons from success. BMJ 2013; 346: f65.
135. Verguet S, Jamison DT. Estimates of performance in the rate of decline of under-fi ve mortality for 113 low-and middle-income countries, 1970-2010. Health Policy Plan 2013; published online Jan 30. DOI:10.1093/heapol/czs143.
136. Norheim OF. Estimated impact on life expectancy and mortality inequality of reducing under-fi ve, maternal, tuberculosis and HIV mortality to a level comparable with four well-performing countries (China, Chile, Costa Rica and Cuba). Commission on Investing in Health Working Paper, 2013. http://globalhealth2035.org (accessed Oct 22, 2013).
137. Horwitz A. Comparative public health: Costa Rica, Cuba, and Chile. September, 1987. http://archive.unu.edu/unupress/ food/8F093e/8F093E04.htm (accessed Oct 17, 2013).
138. World Health Organization. World Health Statistics. 2013. http:// apps.who.int/gho/data/node.main.1?lang=en (accessed Oct 3, 2013).
139. UNAIDS. Report on the Global AIDS Epidemic, 2012. Geneva: Joint United Nations Programme on HIV/AIDS, 2012.
140. AVERT. HIV and AIDS in India. http://www.avert.org/ hiv-aids-india.htm (accessed Oct 3, 2013).
141. India UNICEF. On World AIDS Day: more pregnant women and children must get treatment. http://www.unicef.org/india/ media-7977.htm (accessed Oct 17, 2013).
142. Cousens S, Blencowe H, Stanton C, et al. National, regional, and worldwide estimates of stillbirth rates in 2009 with trends since 1995: a systematic analysis. Lancet 2011; 377: 1319-30.
143. Taskforce on Innovative International Financing for Health Systems. Constraints to scaling up and costs: working group 1 report. Geneva: International Health Partnership, 2009.
144. Schwartländer B, Stover J, Hallett T, et al, and the Investment Framework Study Group. Towards an improved investment approach for an eff ective response to HIV/AIDS. Lancet 2011; 377: 2031-41.
145. Bhutta ZA, Das JK, Walker N, et al. Interventions to address deaths from childhood pneumonia and diarrhoea equitably: what works and at what cost? Lancet 2013; 381: 1417-29.
146. The International Health Partnership. OneHealth Tool. http:// www.internationalhealthpartnership.net/en/tools/one-health-tool/ (accessed April 25, 2013).
147. Futures Institute. OneHealth Tool. 2011. http://www. futuresinstitute. org/onehealth.aspx (accessed Oct 17, 2013).
148. WHO. Essential interventions, commodities and guidelines for reproductive, maternal, newborn and child health. World Health Organization, Aga Khan University, PMNCH, 2012. http://www. who.int/pmnch/topics/part- publications/essential-interventions- 18-01-2012.pdf (accessed Oct 21, 2013).
149. Stenberg K, Axelson H, Sheehan P, et al. Advancing social and economic development by investing in women's and children's health: a new Global Investment Framework. Lancet 2013; published online Nov 19. DOI:10.1016/S0140- 6736(13)62231-X.
150. Roll Back Malaria. Global Malaria Action Plan. 2011. http://www. rbm.who.int/rbmgmap.html (accessed Oct 17, 2013).
151. Seddoh A, Onyeze A, Gyapong JO, Holt J, Bundy D. Towards an investment case for neglected tropical diseases. Commission on Investing in Health Working Paper, 2013. http://globalhealth2035. org (accessed Oct 22, 2013).
152. Molyneux DH, Hotez PJ, Fenwick A. "Rapid-impact interventions": how a policy of integrated control for Africa's neglected tropical diseases could benefi t the poor. PLoS Med 2005; 2: e336.
153. Jamison DT, Evans JR, King T, Porter I. China: the health sector. Washington, DC: World Bank, 1984.
154. Pearson TA, Jamison DT, Trejo-Guttierez J. Cardiovascular disease. In: Jamison DT, Mosley WH, Meashem AR, Bobadilla JL, eds. Disease control priorities in developing countries, 1st edn. New York: Oxford University Press, 1993: 577-94.
155. Jha P, Ramasundarahettige C, Landsman V, et al. 21st-century hazards of smoking and benefi ts of cessation in the United States. N Engl J Med 2013; 368: 341-50.
156. Wen M, Gu D. Air pollution shortens life expectancy and health expectancy for older adults: the case of China. J Gerontol A Biol Sci Med Sci 2012; 67: 1219-29.
157. Whitlock G, Lewington S, Sherliker P, et al, and the Prospective Studies Collaboration. Body-mass index and cause-specifi c mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009; 373: 1083-96.
158. Westphal SA. Obesity, abdominal obesity, and insulin resistance. Clin Cornerstone 2008; 9: 23-29.
159. Reilly JJ, Kelly J. Long-term impact of overweight and obesity in childhood and adolescence on morbidity and premature mortality in adulthood: systematic review. Int J Obes 2011; 35: 891-98.
160. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2224-60.
161. Mozaff arian D, Capewell S. United Nations' dietary policies to prevent cardiovascular disease. BMJ 2011; 343: d5747.
162. Chisholm D, Naci H, Hyder AA, Tran NT, Peden M. Cost eff ectiveness of strategies to combat road traffi c injuries in sub-Saharan Africa and South East Asia: mathematical modelling study. BMJ 2012; 344: e612.
163. WHO. Scaling up action against noncommunicable diseases: how much will it cost? 2011. http://www.who.int/nmh/publications/ cost-of-inaction/en/ (accessed Oct 3, 2013).
164. WHO. Prevention and control of NCDs: priorities for investment. Discussion paper for the First Global Ministerial Conference on Healthy Lifestyles and Noncommunicable Disease Control. Geneva: World Health Organization, 2011.
165. Chaloupka FJ, Yurekli A, Fong GT. Tobacco taxes as a tobacco control strategy. Tob Control 2012; 21: 172-80.
166. Guindon GE, Tobin S, Yach D. Trends and aff ordability of cigarette prices: ample room for tax increases and related health gains. Tob Control 2002; 11: 35-43.
167. Jha P, Joseph R, Li D, et al. Tobacco taxes: a win-win measure for fi scal space and health. Mandaluyong City, Philippines: Asian Development Bank, 2012.
168. Nelson TF, Xuan Z, Babor TF, et al. Effi cacy and the strength of evidence of U.S. alcohol control policies. Am J Prev Med 2013; 45: 19-28.
169. Verguet S, Gauvreau C, Mishra S, et al. Tobacco taxation in China: an extended cost-eff ectiveness analysis. Disease Control Priorities in Developing Countries, 3rd edn. Working Paper no. 4. Seattle: University of Washington, 2013. http://www.dcp-3.org/resources/ tobacco-taxation-china-extended-cost-eff ectiveness-analysis (accessed Oct 17, 2013).
170. Mozaff arian D, Appel LJ, Van Horn L. Components of a cardioprotective diet: new insights. Circulation 2011; 123: 2870-91.
171. Mozaff arian D, Hao T, Rimm EB, Willett WC, Hu FB. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med 2011; 364: 2392-404.
172. Jou J, Techakehakij W. International application of sugar-sweetened beverage (SSB) taxation in obesity reduction: factors that may infl uence policy eff ectiveness in country-specifi c contexts. Health Policy 2012; 107: 83-90.
173. Jamison DT, Leslie J, Musgrove P. Malnutrition and dietary protein: evidence from China and from international comparisons. Food Nutr Bull 2003; 24: 145-54.
174. Mytton OT, Clarke D, Rayner M. Taxing unhealthy food and drinks to improve health. BMJ 2012; 344: e2931.
175. International Monetary Fund. Energy subsidy reform: lessons and implications. Washington, DC: International Monetary Fund, 2013.
176. Aldy JE. Designing energy and environmental fi scal instruments to improve public health. Commission on Investing in Health Working Paper, 2013. http://globalhealth2035.org (accessed Oct 22, 2013).
177. Rivera J, Cordero S. Mexico: healthy food in schools-by law. World Nutrition volume 3, number 11, November 2012. http:// www.wphna.org/2012-nov- wn3-legislation-obesity.htm (accessed Oct 17, 2013).
178. Clancy L, Goodman P, Sinclair H, Dockery DW. Eff ect of air-pollution control on death rates in Dublin, Ireland: an intervention study. Lancet 2002; 360: 1210-14.
179. WHO. World report on road traffi c injury prevention, 2004. Geneva: World Health Organization, 2004.
180. Mann JJ, Apter A, Bertolote J, et al. Suicide prevention strategies: a systematic review. JAMA 2005; 294: 2064-74.
181. Baumgartner J, Smith KR, Chockalingam A. Reducing cardiovascular diseases through improvements in household energy: implications for policy-relevant research. Global Heart 2012; 7: 243-47.
182. Institute of Medicine. Accelerating progress in obesity prevention: solving the weight of the nation, 2011. http://www.iom.edu/ Reports/2012/ Accelerating Progress-in-ObesityPrevention.aspx (accessed Oct 17, 2013).
183. Sandy LG, Tuckson RV, Stevens SL. UnitedHealthcare experience illustrates how payers can enable patient engagement. Health Aff 2013; 32: 1440-45.
184. Sacks G, Rayner M, Swinburn B. Impact of front-of-pack 'traffi c-light' nutrition labelling on consumer food purchases in the UK. Health Promot Int 2009; 24: 344-52.
185. Elbel B, Kersh R, Brescoll VL, Dixon LB. Calorie labeling and food choices: a fi rst look at the eff ects on low-income people in New York City. Health Aff 2009; 28: w1110-21.
186. Mozaff arian D, Stampfer MJ. Removing industrial trans fat from foods. BMJ 2010; 340: c1826.
187. Larson N, Story M. Menu labeling: does providing nutrition information at the point of purchase aff ect consumer behavior? A research synthesis. Healthy Eating Research, Robert Wood Johnson Foundation, June 2009. http://www. healthyeatingresearch.org/images/stories/her-research-briefs/ her-menu-labeling-brief-06-29-09-fi nal.pdf (accessed Oct 17, 2013).
188. Rodgers A, Patel A, Berwanger O, et al, and the PILL Collaborative Group. An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk. PLoS One 2011; 6: e19857.
189. WHO. Investing in mental health: evidence for action. Geneva: World Health Organization, 2013.
190. Debas HT, Gosselin R, McCord C, Thind A. 2006. Surgery. In: Jamison DT, Breman JG, Measham AR, et al, eds. Disease control priorities in developing countries, 2nd edn. New York: Oxford University Press, 2006: 1245-59.
191. Norton R, Kobusingye O. Injuries. N Engl J Med 2013; 368: 1723-30.
192. Gaziano T, Reddy KS, Paccaud F, Horton S, Chatuverdi V. Cardiovascular disease. In: Jamison DT, Breman JG, Measham AR, Alleyne G, et al, eds. Disease control priorities in developing countries, 2nd edn. New York: Oxford University Press, 2006: 645-62.
193. Bukhman G, Kidder A, eds. The PIH guide to chronic care integration for endemic non-communicable diseases. Partners in Health, Harvard Medical School, Brigham and Women's Hospital, 2011. http://www.pih.org/library/the-pih-guide- tochronic-care-integration-for-endemic-non-communicable-dise (accessed Oct 17, 2013).
194. Gupta S, Clements B, Coady D. The challenge of health care reform in advanced and emerging economies. In: Clements B, Coady D, Gupta S, eds. The economics of public health care reform in advanced and emerging economies. Washington, DC: International Monetary Fund, 2012: 3-21.
195. World Bank. World Development Indicators 2012. Washington, DC: World Bank, 2012.
196. Africa Progress Panel. 2013 Africa Progress Report-equity in extractives: stewarding Africa's natural resources for all. 2013. http://www. africaprogresspanel.org/en/publications/africaprogress-report-2013/ apr-documents/ (accessed Oct 17, 2013).
197. Pablos-Méndez A, Tabish H, de Ferranti D. The cost disease and global health. In: Baumol W, ed. The cost disease: why computers get cheaper and health care doesn't. New Haven: Yale University Press, 2012: 94-108.
198. WHO. Health systems fi nancing: the path to universal coverage. 2010. http://www.who.int/whr/2010/en/index.html (accessed Feb 4, 2013).
199. Bobadilla JL, Cowley P, Musgrove P, Saxenian H. Design, content and fi nancing of an essential national package of health services. Bull World Health Organ 1994; 72: 653-62.
200. Wagstaff A. Measuring fi nancial protection in health. In: Smith, PC, Mossialos E, Papanicolas I, Leatherman S, eds. Performance measurement for health system improvement. Cambridge: Cambridge University Press, 2010: 114-37.
201. Central Offi ce of Information. The new National Health Service. Leafl et prepared for the Ministry of Health. London: Central Offi ce of Information, 1948.
202. Moreno-Serra R, Millett C, Smith PC. Towards improved measurement of fi nancial protection in health. PLoS Med 2011; 8: e1001087.
203. Finkelstein A, McKnight R. What did Medicare do (and was it worth it)? NBER Working Paper Series no. 11609. September, 2005. http://www.nber.org/ papers/w11609 (accessed Oct 17, 2013).
204. Enthoven A, Kronick R. A consumer-choice health plan for the 1990s. Universal health insurance in a system designed to promote quality and economy (1). N Engl J Med 1989; 320: 29-37.
205. Roberts MJ, Hsiao W, Berman P, Reich MR. Getting health reform right: a guide to improving performance and equity. New York: Oxford University Press, 2004.
206. WHO. The world health report 2000-health systems: improving performance. Geneva: World Health Organization, 2000.
207. WHO. The world health report 2010-health systems fi nancing: the path to universal coverage. Geneva: World Health Organization, 2010.
208. Verguet S, Laxminarayan R, Jamison DT. Universal public fi nance of tuberculosis treatment in India: an extended cost-eff ectiveness analysis. Health Econ (in press).
209. Smith PC. Incorporating fi nancial protection into decision rules for publicly fi nanced healthcare treatments. Health Econ 2013; 22: 180-93.
210. Giedion U, Alfonso EA, Díaz Y. The impact of universal coverage schemes in the developing world: a review of the existing evidence. Washington, DC: World Bank, 2013.
211. Hernández-Torres J, Avila-Burgos L, Valencia-Mendoza A, Poblano-Verástegui O. [Seguro Popular's initial evaluation of household catastrophic health spending in Mexico]. Rev Salud Publica 2008; 10: 18-32 [in Spanish].
212. Evans TG, Chowdhury AMR, Evans DB, et al. Thailand's universal coverage scheme: achievements and challenges. Bangkok: Health Insurance System Research Offi ce, 2012.
213. Limwattananon S, Tangcharoensathien V, Prakongsai P. Catastrophic and poverty impacts of health payments: results from national household surveys in Thailand. Bull World Health Organ 2007; 85: 600-06.
214. Wagstaff A, Yu S. Do health sector reforms have their intended impacts? The World Bank's Health VIII Project in Gansu Province, China. J Health Econ 2007: 26: 505-35.
215. Gwatkin DR, Ergo A. Universal health coverage: friend or foe of equity? Lancet 2011; 377: 2160-61.
216. Brundtland GH. Message from the Director General. World Health Report, World Health Organization, 1999. http://www.who.int/ whr/1999/en/whr99- dgmessage-en.pdf (accessed Oct 17, 2013).
217. Bosch M, Cobacho MB, Pages C. Taking stock of nine years of implementation of Seguro Popular in Mexico: lessons for developing countries. 2012. http://siteresources.worldbank.org/ EXTLACOFFICEOFCE/Resources/870892- 1265238560114/ CPagesPaper.pdf (accessed Oct 17, 2013).
218. World Bank. Mexico's system for social protection in health and the formal sector. A literature review. Human Development Department, Latin America and the Caribbean Regional Offi ce. Washington, DC: The World Bank, 2012.
219. Towse A, Mills A, Tangcharoensathien V. Learning from Thailand's health reforms. BMJ 2004; 328: 103-05.
220. Limwattananon S, Tangcharoensathien V, Tisayaticom K, Boonyapaisarncharoen T, Prakongsai P. Why has the Universal Coverage Scheme in Thailand achieved a pro-poor public subsidy for health care? BMC Public Health 2012; 12 (suppl 1): S6.
221. Sekhri N, Savedoff W. Regulating private health insurance to serve the public interest: policy issues for developing countries. Int J Health Plann Manage 2006; 21: 357-92.
222. Frakt A. Almost any cost is catastrophic if you are poor. 2013. http://www.nytimes.com/roomfordebate/2013/05/06/moremedicaid-more-health/ almost-any-cost-is-catastrophic-if-yourepoor (accessed Oct 17, 2013).
223. Organisation for Economic Co-operation and Development. Health status. 2013. http://stats.oecd.org/index.aspx? DataSetCode= HEALTH-STAT (accessed Oct 17, 2013).
224. Cheng T-M. Taiwan Province of China's experience with universal health coverage. In: Clements B, Coady D, Gupta S, eds. The economics of public health care reform in advanced and emerging economies. Washington, DC: International Monetary Fund, 2012: 253-79.
225. Stabile M, Thomson S, Allin S, et al. Health care cost containment strategies used in four other high-income countries hold lessons for the United States. Health Aff 2013; 32: 643-52.
226. Figueras J, Robinson R, Jakubowski E. Purchasing to improve health systems performance. Maidenhead: Open University Press, 2005. http://www.euro.who.int/--data/assets/pdf-fi le/0004/98428/ E86300.pdf.
227. Loevinsohn B, Harding A. Buying results? Contracting for health service delivery in developing countries. Lancet 2005; 366: 676-81.
228. Evans D. Contracting and health. Bull World Health Organ 2006; 84: 850-51.
229. House of Commons Health Committee. Commisssion. 2010. http://www.publications.parliament.uk/pa/cm200910/cmselect/ cmhealth/268/268i. pdf#page=10 (accessed Oct 17, 2013).
230. Oxley H. Improving health care system performance through better coordination of care. In: Achieving better value for money in health care. Paris: Organisation for Economic Co-operation and Development, 2009: 79-100.
231. Bloom D, Cafi ero E, Jané-Llopis E, et al. The global burden of noncommunicable diseases. Geneva: World Economic Forum, 2011.
232. Colombo F, Tapay N. Private health insurance in OECD countries: the benefi ts and costs for individuals and health systems. Organisation for Economic Co-operation and Development, 2004. http://www.oecd. org/els/health-systems/33698043.pdf (accessed Oct 17, 2013).
233. WHO. National health accounts database. http://apps.who.int/nha/ database/DataExplorerRegime.aspx (accessed Oct 17, 2013).
234. Baicker K, Goldman D. Patient cost-sharing and healthcare spending growth. J Econ Perspect 2011; 25: 47-68.
235. Krivelli E, Leive A, Stratmann T. Subnational health spending and soft budget constraints in OECD countries. IMF Working paper 2010. http://www.imf.org/external/pubs/ft/wp/2010/wp10147.pdf (accessed Oct 3, 2013).
236. Calsyn M, Lee EO. Alternatives to fee-for-service payments in health care. 2012. http://www.americanprogress.org/wp-content/uploads/ 2012/09/FeeforService-1.pdf (accessed Oct 17, 2013).
237. Feachem RGA, Sekhri NK, White KL. Getting more for their dollar: a comparison of the NHS with California's Kaiser Permanente. BMJ 2002; 324: 135-41.
238. Chen JY, Tian H, Taira Juarez D, et al. The eff ect of a PPO pay-for-performance program on patients with diabetes. Am J Manag Care 2010; 16: e11-19.
239. Basinga P, Gertler PJ, Binagwaho A, Soucat ALB, Sturdy J, Vermeersch CMJ. Eff ect on maternal and child health services in Rwanda of payment to primary health-care providers for performance: an impact evaluation. Lancet 2011; 377: 1421-28.
240. Bonfrer I, Soeters R, van de Poel E, et al. The eff ects of performance-based fi nancing on the use and quality of health care in Burundi: an impact evaluation. Lancet 2013; 381: S19.
241. Witter S, Fretheim A, Kessy FL, Lindahl AK. Paying for performance to improve the delivery of health interventions in low-and middle-income countries. Cochrane Database Syst Rev 2012; 2: CD007899.
242. Lee JL, Fischer MA, Shrank WH, Polinski JM, Choudhry NK. A systematic review of reference pricing: implications for US prescription drug spending. Am J Manag Care 2012; 18: e429-37.
243. United Nations Development Programme. Human Development Report 1994. New Dimensions of Human Security. New York and Oxford: Oxford University Press, 1994.
244. Brundtland GH, Sachs J, Feachem RGA. World Health Organization and Commission on Macroeconomics and Health. Working Group 2. Global public goods for health: The report of Working Group 2 of the Commission on Macroeconomics and Health. Geneva: World Health Organization, 2002.
245. WHO. Eleventh General Programme of Work. Geneva: World Health Organization, 2010. http://apps.who.int/gb/ebwha/ pdf-fi les/WHA63/A63-30-en.pdf (accessed Oct 17, 2013).
246. Jamison DT, Frenk J, Knaul F. International collective action in health: objectives, functions, and rationale. Lancet 1998; 351: 514-17.
247. Frenk J, Moon S. Governance challenges in global health. N Engl J Med 2013; 368: 936-42.
248. IJsselmuiden CI. Matlin. Why health research? 2006. http:// whqlibdoc.who.int/publications/2006/2940286477-eng.pdf (accessed Oct 17, 2013).
249. Hecht R, Jamison DT. Vaccine research and development assessment paper. In: Lomborg B, ed. Rethink HIV: smarter ways to invest in ending HIV in sub-Saharan Africa. New York: Cambridge University Press, 2012: 299-320.
250. Goldie SJ, Sweet S. Research and development. Commission on Investing in Health Working Paper. 2013. http://globalhealth2035. org (accessed Oct 22, 2013).
251. Torjesen I. Antimicrobial resistance presents an "apocalyptic" threat similar to that of climate change, CMO warns. BMJ 2013; 346: f1597.
252. Global Alliance for TB Drug Development. MDR-TB/XDR-TB. 2013. http://www.tballiance.org/why/mdr-xdr.php (accessed Aug 10, 2013).
253. Lightfoot N, Rweyemamu M, Heymann DL. Preparing for the next pandemic. BMJ 2013; 346: f364.
254. Jamison DT, Jha P, Malhotra V, Verguet S. Human health: the twentieth century transformation of human health-its magnitude and value. In: Lomborg B, ed. How much have global problems cost the world? A scorecard from 1900 to 2050. Cambridge: Cambridge University Press, 2013: 207-46.
255. Liu J, Modrek S, Gosling RD, Feachem RGA. Malaria eradication: is it possible? Is it worth it? Should we do it? Lancet Glob Health 2013; 1: e2-3.
256. The Global Health Group. Maintaining the gains in global malaria control: the health and economic benefi ts of sustaining control measures. October, 2011. http://MaintainTheGains.org (accessed Aug 8, 2013).
257. Ebrahim S, Pearce N, Smeeth L, Casas JP, Jaff ar S, Piot P. Tackling non-communicable diseases in low-and middle-income countries: is the evidence from high-income countries all we need? PLoS Med 2013; 10: e1001377.
258. Yamey G. Scaling up global health interventions: a proposed framework for success. PLoS Med 2011; 8: e1001049.
259. Black AD, Car J, Pagliari C, et al. The impact of eHealth on the quality and safety of health care: a systematic overview. PLoS Med 2011; 8: e1000387.
260. Free C, Phillips G, Watson L, et al. The eff ectiveness of mobile-health technologies to improve health care service delivery processes: a systematic review and meta-analysis. PLoS Med 2013; 10: e1001363.
261. Downs S, Montagu D, Da Rita P, Brashers E, Feachem RGA. Health system innovation in Lesotho: design and early operations of the Maseru public-private integrated partnership. Healthcare public-private partnerships series, no. 1. San Francisco: The Global Health Group, Global Health Sciences, University of California, San Francisco, and PwC, 2013.
262. Bloomberg MR. Why is Obama caving on tobacco? New York Times (New York), August 22, 2013.
263. Lee K, Collin J. "Key to the future": British American tobacco and cigarette smuggling in China. PLoS Med 2006; 3: e228.
264. Lagomarsino G, Garabrant A, Adyas A, Muga R, Otoo N. Moving towards universal health coverage: health insurance reforms in nine developing countries in Africa and Asia. Lancet 2012; 380: 933-43.
265. Berman P, Bitran R. Health systems analysis for better health systems strengthening. World Bank HNP Discussion Paper. Washington, DC: The World Bank, 2011.
266. Barrett S. Economic considerations for the eradication endgame. Philos Trans R Soc Lond B Biol Sci 2013; 368: 20120149.
267. Røttingen J-A, Chamas C. A new deal for global health R&D? The recommendations of the Consultative Expert Working Group on Research and Development (CEWG). PLoS Med 2012; 9: e1001219.
268. WHO Ad Hoc Committee on Health Research Relating to Future Intervention Options. Investing in health research and development. Geneva: World Health Organization, 1996.